FDA Approved: CAVERJECT IMPULSE — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for CAVERJECT IMPULSE (alprostadil) to update the labeling for this erectile dysfunction therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• CAVERJECT IMPULSE (ALPROSTADIL)

Snippet

SUPPL AP for CAVERJECT IMPULSE (ALPROSTADIL)